Login to Your Account

Preclinical Inventisbio raises $19M from Orbimed, LAV

By Shannon Ellis
Staff Writer

Tuesday, June 13, 2017

SHANGHAI – Inventisbio Inc., has emerged from stealth, nabbing $19 million in series B financing from health care venture financiers Orbimed and Lilly Asia Ventures (LAV).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription